Literature DB >> 10618127

Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia.

J Kónya1, G Veress, A Juhász, K Szarka, T Sápy, Z Hernádi, L Gergely.   

Abstract

The type specificity of the human papillomavirus (HPV) Hybrid Capture Tube (HCT) test was evaluated by using typing with PCR (MY09-MY11)-restriction fragment length polymorphism (RFLP) and sequencing. All samples HCT test positive for only low-risk HPV (n = 15) or only high-risk HPV (n = 102) were confirmed, whereas 9 of 12 HCT test double-positive samples contained only high-risk HPV types as determined by PCR-RFLP. Several high-risk HPV types (HPV-53, -58, -62, -66, -CP8304, and -MM4) not included in the HCT test were indeed detected, indicating a broader detection range with retained distinction between low-risk and high-risk HPV types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618127      PMCID: PMC88735          DOI: 10.1128/JCM.38.1.408-411.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Anal and cervical abnormality in women--prediction by human papillomavirus tests.

Authors:  M Melbye; E Smith; J Wohlfahrt; A Osterlind; M Orholm; O J Bergmann; L Mathiesen; T M Darragh; J M Palefsky
Journal:  Int J Cancer       Date:  1996-11-27       Impact factor: 7.396

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  Human papillomavirus distribution in cervical tissues of different morphology as determined by hybrid capture assay and PCR.

Authors:  I Nindl; C Greinke; D M Zahm; E Stockfleth; H Hoyer; A Schneider
Journal:  Int J Gynecol Pathol       Date:  1997-07       Impact factor: 2.762

4.  Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms.

Authors:  H U Bernard; S Y Chan; M M Manos; C K Ong; L L Villa; H Delius; C L Peyton; H M Bauer; C M Wheeler
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

5.  Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.

Authors:  M H Schiffman; N B Kiviat; R D Burk; K V Shah; R W Daniel; R Lewis; J Kuypers; M M Manos; D R Scott; M E Sherman
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

6.  Persistence of type-specific human papillomavirus infection among cytologically normal women.

Authors:  A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

7.  Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study.

Authors:  A Ferenczy; E Franco; J Arseneau; T C Wright; R M Richart
Journal:  Am J Obstet Gynecol       Date:  1996-09       Impact factor: 8.661

8.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors:  J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

9.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

10.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.

Authors:  G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney
Journal:  J Natl Cancer Inst       Date:  1995-09-20       Impact factor: 13.506

View more
  2 in total

1.  High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma.

Authors:  G Szládek; A Juhász; G Kardos; K Szoke; T Major; I Sziklai; I Tar; I Márton; J Kónya; L Gergely; K Szarka
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

2.  Survivin promoter polymorphism and cervical carcinogenesis.

Authors:  A A Borbély; M Murvai; K Szarka; J Kónya; L Gergely; Z Hernádi; G Veress
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.